慢性乙型肝炎与IFNγ、IL-4的关系

翁美玲; 张国梁; 吴文泽; 施美; 刘丽丽

doi:10.3969/j.issn.1001-5256.2016.10.039

慢性乙型肝炎与IFNγ、IL-4的关系

DOI: 10.3969/j.issn.1001-5256.2016.10.039

1. 安徽中医药大学
2. 安徽中医药大学第一附属医院

基金项目:

安徽省自然基金项目上(1408085QH185)；徐经世国医大师传承工作室项目；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 1828
- HTML全文浏览量: 9
- PDF下载量: 427
- 被引次数: 0
出版历程
- 出版日期: 2016-10-20

Association of chronic hepatitis B with interferon-γ and interleukin-4

Anhui University of Chinese Medicine

Research funding:

摘要

摘要:
慢性乙型肝炎（CHB）的发病机制主要是机体免疫功能特异性损伤,最终导致HBV感染的慢性化。现代研究表明,激活的特异性炎症细胞及其所释放的细胞因子IFNγ、IL-4,在病毒清除及提高机体自身免疫功能方面发挥重要作用。随着祖国医学的不断发展,中医药对免疫调控系统（特别是IFNγ、IL-4等）也产生广泛的影响。就近年来中西医有关CHB免疫机制研究进展进行阐述,为中医药从免疫调控角度打破CHB的免疫耐受提供新的思路和对策。
- 肝炎,乙型,慢性 /
- 免疫疗法 /
- 干扰素Ⅱ型 /
- 白细胞介素4 /
- 综述
Abstract:
The pathogenesis of chronic hepatitis B( CHB) is mainly chronicity of hepatitis B virus infection caused by specific immune impairment. Modern studies have shown that activated specific inflammatory cells and the cytokines released by these cells such as interferon-γ( IFN-γ) and interleukin-4( IL-4) play important roles in virus clearance and improvement of autoimmune function. With the constant development of traditional Chinese medicine,it has a widespread effect on the immune regulation system( especially IFN-γ and IL-4). This article reviews the research advances in immunologic mechanism if CHB in Chinese and Western medicine in recent years and provides new ideas and measures for traditional Chinese medicine to break the immune tolerance of CHB in terms of immune regulation.
- hepatitis B /
- chronic /
- immunotherapy /
- interferon type Ⅱ /
- interleukin-4

HTML全文

参考文献(44)

[1]LI CD,CHEN XL,TIAN PF,et al.Correlation analysis of percentages of T lymphocyte subsets and CD4+CD25+regulatory T cells and HBV DNA level in peripheral blood of chronic hepatitis B patients[J].J Clin Hepatol,2015,31(4):541-545.(in Chinese)李彩东,陈锡莲,田鹏飞,等.慢性乙型肝炎患者外周血中T淋巴细胞亚群和CD4+CD25+调节性T淋巴细胞的表达水平与HBV DNA定量的相关分析[J].临床肝胆病杂志,2015,31(4):541-545.

[2]SHIMIZU Y.T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection[J].World J Gastroenterol,2012,18(20):2443-2451.

[3]SAXENA R,KAUR J.Th1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinoma[J].World J Gastroenterol,2015,7(11):1572-1580.

[4]CAO XT.Medical immunology[M].Beijing:People's Medical Publishing House,2013:49-172.(in Chinese)曹雪涛.医学免疫学[M].北京:人民卫生出版社,2013:49-172.

[5]FEI Y,CHEN Y,WU WY.Research advances in relationship between interleukins and hepatitis B virus infection[J].J Clin Hepatol,2014,30(2):174-177.(in Chinese)费筠,陈月,吴文苑.白细胞介素与HBV感染的关系[J].临床肝胆病杂志,2014,30(2):174-177.

[6]HUANG HF,HE DM,WU QX,et al.HBe Ag changes in serum levels of Th1/Th2 cytokines in HBe Ag-positive pregnant women with HBV infection after telbivu dine treatment[J].J Clin Hepatol,2014,30(6):522-526.(in Chinese)黄鸿菲,何登明,吴全新,等.HBe Ag阳性慢性乙型肝炎孕妇替比夫定治疗前后血清Th1/Th2型细胞因子的水平变化[J].临床肝胆病杂志,2014,30(6):522-526.

[7]Mc NICHOLL JM,DOWNER MV,UDHAYAKUMAR V,et al.Hostpathogen interactions in emerging and re-emerging infectious diseases:a genomic perspective of tuberculosis,malaria,human immunodeficiency virus infection,hepatitis B,and cholera[J].Annu Rev Public Health,2000,21(1):15-46.

[8]TUNGILEK S.Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection[J].World J Gastroenterol,2014,20(20):6226-6235.

[9]LI M,ZHOU ZH,SUN XH,et al.The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection[J].Hepatol Int,2016,10(4):594-601.

[10]JIANG RL,LU QS,HOU JL.Polarized populations of T helper cells in patients with chronic hepatitis B virus infection[J].Natl Med J China,2000,80(10):741-744.(in Chinese)姜荣龙,卢桥生,侯金林.辅助性T细胞极化群体在慢性乙型肝炎病毒感染中的作用[J].中华医学杂志,2000,80(10):741-744.

[11]PRINCIPI N,ESPOSITO S,BLASI F,et al.Role of mycoplasma pneumoniae and chlamydia pneumoniae in children with community-acquired lower respiratory tract infections[J].Clin Infect Dis,2001,32(9):1281-1289.

[12]WANG Y,HU XB,DING XX.The influence of PEG-IFN-α2a on the expression of ICOS on CD4+T cells and the levels of IFN-γand IL-4 in sera of patients with chronic hepatitis B[J].Chin J Microecol,2012,24(1):43-46.(in Chinese)王瑜,胡孝彬,丁晓霞.长效干扰素对CHB患者CD4+T细胞ICOS表达及血清IFN-γ、IL-4水平的影响[J].中国微生态学杂志,2012,24(1):43-46.

[13]FALASCA K,UCCIFERRI C,DALESSANDRO M,et al.Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C[J].Ann Clin Lab Sci,2006,36(2):144-150.

[14]LALOR PF,SHIELDS P,GRANT A,et al.Recruitment of lymphocytes to the human liver[J].Immunol Cell Biol,2002,80(1):52-64.

[15]CRISPE IN.The liver as a lymphoid organ[J].Annu Rev Immunol,2009,27(1):147-163.

[16]PENNA A,DEL PRETE G,CAVALLI A,et al.Predominant Thelper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B[J].Hepatology,1997,25(4):1022-1027.

[17]CHISARI FV,FERRARI C.Hepatitis B virus immunopathogenesis[J].Annu Rev Immunol,1995,13(4):29-60.

[18]ROMAGNANI S.Lymphokine production by human T cells in disease states[J].Annu Rev Immunol,1994,12(12):227-257.

[19]BALATO A,UNUTMAZ D,GASPARI AA.Natural killer T cells:an unconventional T-cell subset with diverse effector and regulatory functions[J].J Invest Dermatol,2009,129(7):1628-1642.

[20]MORETTA L,FEALAZZO G,BOTTINO C,et al.Effector and regulatory events during natural killer-dendritic cell interactions[J].Immunol Rev,2006,214(1):219-228.

[21]GAO QJ,LIU DW,ZHANG SY,et al.Polymorphisms of some cytokines and chronic hepatitis B and C virus infection[J].World J Gastroenterol,2009,15(44):5610-5619.

[22]XI HL,LIU FF,YUAN JY,et al.Significance and detection of IL-2,IL-4 and IFN-γin PBMC from patients with hepatitis B virus infection[J].J Clin Hepatol,2010,26(6):627-629.(in Chinese)席宏丽,柳芳芳,袁家颍,等.乙型肝炎病毒感染者外周血单个核细胞内IL-2、IL-4和IFN-γ检测及意义[J].临床肝胆病杂志,2010,26(6):627-629.

[23]LI M,SUN XH,ZHOU ZH,et al.Alterations of IFN-γand IL-4 of peripheral blood T cells in patients with chronic HBV infection[J].Chin J Cell Mol Immunol,2016,32(2):240-244.(in Chinese)李曼,孙学华,周振华,等.慢性乙型肝炎病毒感染者外周血T细胞γ干扰素和白细胞介素4的水平变化[J].细胞与分子免疫学杂志,2016,32(2):240-244.

[24]LIU J,SHENG JF.Study on Th1/Th2 cytokines in serum of chronic hepatitis B patients[J].Inter J Epidemiol Infect Dis,2006,33(1):15-18.(in Chinese)刘骏,盛吉芳.慢性乙型肝炎患者血清Th1/Th2型细胞因子水平研究[J].国际流行病学传染病学杂志,2006,33(1):15-18.

[25]LI CH,CHEN Y,HUANG X,et al.Effect of LPSp on the secretions of IL-4 and IFN-γby mononuclear cells and TLR4 expression in umbilical cord blood of pregnant women with HBV intrauterine infection[J].Matern Child Health Care China,2012,27(12):1856-1858.(in Chinese)李常虹,陈悦,黄星,等.LPSp对HBV宫内感染脐血单个核细胞分泌IL-4、IFN-γ及TLR4表达的影响[J].中国妇幼保健,2012,27(12):1856-1858.

[26]WANG C,JIANG YF,JIN QL,et al.The detection of cytokines IFN-γ、TNF-α、IL-4、IL-10 in the serum of patients of liver disease[J].J Clin Hepatol,2009,25(2):99-101.(in Chinese)王崇,姜艳芳,金清龙,等.肝脏疾病患者血清细胞因子IFN-γ、TNF-α、IL-4、IL-10的检测[J].临床肝胆病杂志,2009,25(2):99-101.

[27]LI Y,ZHANG HM,SHEN JF.Association of interleukin-2,interferon-γ,interleukin-4,and interleukin-6 with intrauterine infection in pregnant women with hepatitis B virus infection[J].Asia-Pacific Tradit Med,2012,8(10):84-85.(in Chinese)李艳,张红梅,沈佳芳.乙型肝炎病毒感染孕妇IL-2、IFN-γ和IL-4、IL-6与宫内感染的相关性研究[J].亚太传统医药,2012,8(10):84-85.

[28] HUANG HF,HE DM,WU QX,et al.Changes in serum levels of Th1/Th2 cytokines in HBe Ag-positive pregnant women with HBV infection after telbivudine treatment[J].J Clin Hepatol,2014,30(6):522-526.(in Chinese)黄鸿菲,何登明,吴全新,等.HBe Ag阳性慢性乙型肝炎孕妇替比夫定治疗前后血清Th1/Th2型细胞因子的水平变化[J].临床肝胆病杂志,2014,30(6):522-526.

[29]MEI Y,HUANG X,HUANG LY.Association of serum HBV DNA,interferon-γ,interleukin-4,and interleukin-6 with intrauterine HBV infection in pregnant women[J].J Guangxi Med Univ,2007,24(2):233-235.(in Chinese)梅艳,黄星,黄力毅.孕妇血清中HBV DNA及IFN-γ、IL-4、IL-6与HBV宫内感染关系的研究[J].广西医科大学学报,2007,24(2):233-235.

[30]LAI ZW,TIAN DB,ZHONG GQ,et al.Effect of lamivudine on levels of serum IFN-γand IL-4 in patients with chronic hepatitis B[J].J Clin Exp Med,2007,6(3):18-19.(in Chinese)赖志伟,田东波,钟国权,等.拉米夫定对慢性乙型肝炎患者血清IFN-γ、IL-4的影响[J].临床和实验医学杂志,2007,6(3):18-19.

[31]BALMASOVA IP,YUSHCHUK ND,MYNBAEV OA,et al.Immunopathogenesis of chronic hepatitis B[J].World J Gastroenterol,2014,20(39):14156-14171.

[32]LIU ZJ,WANG ZL,SUN XH,et al.Effect of modified Xiaochaihu decoction on expression of IL-12,IL-4 and IFN-γmRNA in HBV transgenic mice[J].Chin J Integr Tradit West Med Liver Dis,2010,20(5):289-290.(in Chinese)刘中景,王者令,孙晓慧,等.加味小柴胡汤对乙肝病毒转基因小鼠白介素-12、白介素-4、干扰素-γmRNA表达的影响[J].中西医结合肝病杂志,2010,20(5):289-290.

[33]LUO JH,CAO QS.Study on correlation between TCM dialectical type and T lymphocyte subsets,IL-4,IFN-γin patients with HBe Agnegative chronic hepatitis B[J].J Yunnan Coll Tradit Chin Med,2014,37(4):1-3,8.(in Chinese)罗俊华,曹秋实.HBe Ag阴性慢性乙型肝炎中医证型与T淋巴细胞亚群及IL-4、IFN-γ相关性研究[J].云南中医学院学报,2014,37(4):1-3,8.

[34]LIU XL,XIONG YQ,ZHOU DQ,et al.Influence of Bushenqingtou decoction on serum IL-2,IL-4,IL-10,TNF-αand IFN-γin chronic hepatitis B patients with positive HBe Ag[J].Int J Lab Med,2014,35(5):565-566,571.(in Chinese)刘心亮,熊益群,周大桥,等.补肾清透方对慢性乙肝HBe Ag阳性患者血清IL-2、-4、IL-10、TNF-α及IFN-γ的影响[J].国际检验医学杂志,2014,35(5):565-566,571.

[35]NI W,SHI WQ,RU QJ,et al.Research of bushen qingtou prescription on cytokines of hepatitis B virus carriers with positive HBe Ag[J].Chin Arch Tradit Chin Med,2015,33(3):543-545.(in Chinese)倪伟,施维群,茹清静,等.补肾清透方对HBe Ag阳性慢性HBV携带者细胞因子的影响研究[J].中华中医药学刊,2015,33(3):543-545.

[36]LI CQ,LIU LL,ZHU YT,et al.Protective effects of Qingganpaiduyin against hepatic immune injury induced by concanavalin A in mice[J].World Chin J Dig,2005,13(11):1283-1286.(in Chinese)李常青,刘丽丽,朱宇同,等.中药清肝排毒饮对刀豆蛋白A所致小鼠免疫性肝损伤的保护作用[J].世界华人消化杂志,2005,13(11):1283-1286.

[37]ZHEN XG,LUO LF.Regulatory effect of kushenin on Th-1/Th-2 balance in peripheral blood in patients with chronic hepatitis B[J].Herald Med,2009,28(1):70-71.(in Chinese)郑贤干,罗利飞.苦参素对慢性乙型肝炎患者外周血Th-1/Th-2平衡的调控作用[J].医药导报,2009,28(1):70-71.

[38]CHEN B,PENG JP,ZHANG T,et al.Effects of tonifying kidney,strengthening spleen and tonifying spleen-kidney on peripheral blood T cells in chronic hepatitis patients[J].J Tradit Chin Med Univ Hunan,2011,31(11):48-51.(in Chinese)陈斌,彭建平,张涛,等.健脾、补肾与健脾补肾三法对慢性乙型肝炎患者外周血T细胞功能的影响[J].湖南中医药大学学报,2011,31(11):48-51.

[39]NIE HM,MEI ZH,GAO YQ,et al.Effect of Bushen recipe on immune effector molecules of T lymphocytes[J].Acta Univ Tradit Med Sin Pharmacol Shanghai,2016,30(2):14-18.(in Chinese)聂红明,梅昭荷,高月求,等.补肾颗粒对慢性乙型肝炎患者CD4+T淋巴细胞整体免疫调控网络的影响[J].上海中医药大学学报,2016,30(2):14-18.

[40]DAI BY,XIONG XT.Influence of combined treatment with TCM acupuncture,moxibustion,and medication on peripheral blood T cell subsets in patients with chronic hepatitis B[J].Jiangxi Tradit Chin Med,2009,40(12):28-29.(in Chinese)戴步英,熊学涛.中医针、灸、药联合治疗对慢性乙型肝炎患者外周血T淋巴细胞亚群的影响[J].江西中医药,2009,40(12):28-29.

[41]TU KY,TAN SZ.Research progress of acupoint injection in treatment of chronic hepatitis B[J].Med Recapitulate,2010,16(22):3431-3433.(in Chinese)徒康苑,谭善忠.穴位注射在慢性乙型肝炎治疗中的作用研究进展[J].医学综述,2010,16(22):3431-3433.

[42]ZHANG Y,YU HY.Effect of injecting thymosinα1 at Zusanli point on T lymphocyte subset in chronic hepatitis B patient[J].Chin J Microecol,2007,19(2):189-192.(in Chinese)张颖,俞海英.穴位注射胸腺肽α-1对慢性乙肝T细胞亚群的影响[J].中国微生态学杂志,2007,19(2):189-192.

[43]JIANG YF,MA ZH,ZHAO PW,et al.Effect of thymosin-α(1)on T-helper 1 cell and T-helper 2 cell cytokine synthesis in patients with hepatitis B virus e antigen-positive chronic hepatitis B[J].J Int Med Res,2010,38(6):2053-2062.

[44]ZHANG YP,YANG QH,LI N,et al.A study on prevention and treatment of chronic hepatitis B from the perspective of immune concepts in traditional Chinese medicine[J].New J Tradit Chin Med,2008,40(10):1-2.(in Chinese)张玉佩,杨钦河,李娜,等.从中医免疫观防治慢性乙型肝炎探析[J].新中医,2008,40(10):1-2.

施引文献

资源附件(0)

访问统计